Production (Stage)
Ekso Bionics Holdings, Inc.
EKSO
$0.2798
$0.00120.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.79M | -11.33M | -11.13M | -12.42M | -14.24M |
| Total Depreciation and Amortization | 1.58M | 1.61M | 1.64M | 1.66M | 1.69M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.69M | 2.40M | 1.08M | 2.13M | 2.21M |
| Change in Net Operating Assets | -823.00K | -2.53M | -1.58M | -2.44M | -969.00K |
| Cash from Operations | -8.35M | -9.85M | -10.00M | -11.07M | -11.31M |
| Capital Expenditure | -39.00K | -37.00K | -59.00K | -68.00K | -123.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -39.00K | -37.00K | -59.00K | -68.00K | -123.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.25M | -1.25M | -1.25M | -938.00K | -626.00K |
| Issuance of Common Stock | 8.89M | 9.02M | 9.68M | 4.68M | 4.63M |
| Repurchase of Common Stock | -2.00K | -2.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.64M | 7.77M | 8.43M | 3.74M | 4.01M |
| Foreign Exchange rate Adjustments | -2.00K | -31.00K | -20.00K | -21.00K | -54.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -745.00K | -2.15M | -1.65M | -7.42M | -7.48M |